Yale Cancer Center Laboratory Study Shows Combination Treatment Effective in IDH Mutant Cancers
A new study led by Yale Cancer Center scientists revealed the combination of ATR and PARP inhibitor therapies can effectively target the enzyme isocitrate dehydrogenase-I/2 (IDH-1/2) in mutant cancer cells.
Yale Cancer Center Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Patient Experience Improves With Open Mask Frameless Stereotactic Radiosurgery
Undergoing stereotactic radiosurgery (SRS) to treat a brain tumor can be daunting enough, without the added stress of wearing a head frame attached to your skull with pins. Thankfully, patients at Smilow Cancer Care Center in Greenwich now have access to open mask frameless SRS.
Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.
Greenwich Hospital Oncologist to Retire after Four Decades of Care
After an outstanding 40-year career, Dickerman Hollister Jr., MD has announced that he will be retiring this month. Beloved by the community, Dr. Hollister has treated multiple generations of Greenwich families with grace, expertise and empathy.
Countdown to Closer to Free Begins with Guilford Survivor and ‘Willpower'
Team Willpower came together after breast cancer survivor Katie Cardoso's brother’s non-Hodgkin's lymphoblastic T-cell lymphoma diagnosis in 2012. They’ve been in Closer to Free, a fundraiser to benefit Smilow, for nine years.Source: NBC Connecticut
Yale Cancer Center Study Shows Neuromuscular Dysfunction in Long-term Childhood Cancer Survivors
In a new study led by Yale Cancer Center researchers, neuromuscular dysfunction is found to be prevalent in long-term childhood cancer survivors, continues to increase post-therapy, and is associated with adverse health and socioeconomic outcomes.
$8.5M Federal Grant Aims for Big Impact from Small Molecules in the Gut
Yale researchers across a range of disciplines are coming together to explore the important role of microbial metabolites in our microbiota—the trillions of bacterial cells that colonize our intestines.Source: Yale West Campus
Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer
A revolutionary new urine screening test that utilizes a novel Keratin 17 (K17) cancer biomarker can detect the presence of new bladder cancer in patients with hematuria, or blood in the urine, according to a study led by researchers at Yale Cancer Center, Stony Brook University, and KDx Diagnostics, Inc. The findings also show the test can detect recurrent bladder cancer in patients under surveillance for relapse. The study was published online today in American Journal of Clinical Pathology.
One Patient’s Dream of Giving Back Supports 14 Families at Smilow
After spending time talking with other cancer patients during her regular appointments at Smilow Cancer Hospital, Nicole Donzello quickly recognized the stress that many patients and families are under during their treatment. “When diagnosed with cancer, it’s heartbreaking to hear how everything is crumbling around many patients. I heard how some were focused on monetary issues versus their health and the amount of stress it caused for them. Patients really need the freedom to focus on themselves,” Nicole explained.
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 90 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2021 Best Doctors guide. Published in the magazine’s June issue, the 'Best Doctors' list consists of more than 1,500 Connecticut physicians from nearly 40 medical specialties.